In RA patients, B cells also express chemokine CCL3 and TNF-α to inhibit osteoblast differentiation by activating the extracellular signal-regulated kinase (ERK) and NF-κB signaling pathways for joint injury (70). Here, CCL3 is linked to rheumatoid arthritis.